If you only glanced at Merck’s headlines over the past year, the story looked messy, with rising revenue but shrinking net margin in the latest quarter and constant debate about life after KEYTRUDA. ...
Source LinkIf you only glanced at Merck’s headlines over the past year, the story looked messy, with rising revenue but shrinking net margin in the latest quarter and constant debate about life after KEYTRUDA. ...
Source Link
Comments